Zu den Inhalten springen

Klinik für Plastische und Handchirurgie

Diagnostic Biomarkers for Soft Tissue Sarcomas

Dr. David Braig

Dr. David Braig

Dr. Anja Eisenhardt

About 50% of soft tissue sarcomas relapse after treatment of the primary tumour. Early detection and treatment of local recurrence or metastasis can significantly improve long-term disease control and survival. Most recurrences develop within 2-3 years after treatment. Closely spaced and efficient follow-up strategies are therefore mandatory to detect recurrence at an early stage.

Current follow-up strategies, which consist of a physical examination and various imaging modalities, lack evidence and are expensive, time consuming and associated with radiation exposure.

Our research aims to develop non-invasive strategies for the diagnosis of soft tissue sarcomas. We want to distinguish patients with active disease from healthy persons by liquid biopsy. Different tumour-induced changes in the peripheral blood of patients with soft tissue sarcomas are targeted. We recently discovered a miRNA signature in the peripheral blood of patients with Synovial Sarcomas, which distinguished them from healthy persons and other sarcoma entities and established sensitive methods for the detection of sarcoma associated fusion genes.

Present research focuses on the detection of free circulating tumour DNA (ctDNA). Highly sensitive methods enable the quantification of tumour-derived ctDNA in the peripheral blood due to tumour-specific DNA alterations. The amount of ctDNA is further analysed in respect to the tumour volume, which is obtained by 3D volume rendering of MRI and CT scans.

"Efficacy and Safety of Microsurgery in Interdisciplinary Treatment of Sarcoma Affecting the Bone." JR Thiele, J Weber, HP Neeff, P Mangegold, S Fichtner-Feigl, GB Stark, SU Eisenhardt et al., Frontiers in Oncology, 2020

"Efficacy and Safety of Microsurgery in Interdisciplinary Treatment of Sarcoma Affecting the Bone." J Zeller, J Kiefer, D Braig, O Winninger, GB Stark, SU Eisenhardt et al., Frontiers in Oncology, 2019

- "Genotyping of circulating cell‐free DNA enables noninvasive tumor detection in myxoid liposarcomas." D Braig, GB Stark, SU Eisenhardt et al., International Journal of Cancer, 2019

- "Whole blood miRNA expression analysis reveals miR-3613-3p as a potential biomarker for dedifferentiated liposarcoma." A Fricke, D Braig, GB Stark, SU Eisenhardt et al., Cancer Biomarkers, 2018

- "Levels of activated platelet-derived microvesicles in patients with soft tissue sarcoma correlate with an increased risk of venous thromboembolism." A Fricke, GB Stark, D Braig, SU Eisenhardt et al., BMC Cancer, 2017

- "Soft Tissue Sarcomas of the Arm – Oncosurgical and Reconstructive Principles within a Multimodal, Interdisciplinary Setting." Koulaxouzidis, F Simunovic et al., Frontiers in Surgery, 2016

- "Synovial Sarcoma Microvesicles Harbor the SYT-SSX Fusion Gene Transcript: Comparison of Different Methods of Detection and Implications in Biomarker Research." A Fricke, D Braig, GB Stark, SU Eisenhardt et al., Stem Cells International, 2016

- "Microsurgical reconstruction of oncological scalp defects in the elderly." F Simunovic, JR Thiele, GB Stark, SU Eisenhardt  et al., Journal of Plastic, Reconstructive & Aesthetic Surgery, 2016

- "An algorithm for oncologic scalp reconstruction." N Iblher, GB Stark, SU Eisenhardt et at., Plastic and Reconstructive Surgery, 2010

Fig. 1: Blood-borne miRNA signature of synovial sarcoma. Hierarchical clustering separated synovial sarcoma samples from healthy controls. Further information can be obtained from https://www.ncbi.nlm.nih.gov/pubmed/26250552.

Fig. 2: Simultaneous detection of tumour DNA from a synovial sarcoma harbouring a SYT-SSX Fusion (blue droplets) within the background of human wild-type DNA (green) by droplet digital PCR.

Fig. 3: 3D volume rendering of a MRI scan from a patient with a soft tissue sarcoma

Aktuelle Informationen

 

Unsere Abteilung hat den elektiven Ambulanzbetrieb wieder aufgenommen

  • Wir bitten Sie Termine zuvor telefonisch oder online zu vereinbaren.
  • Das Tragen eines Mundschutzes in der Klinik ist verpflichtend.
  • Wir bitten Sie um das Einhalten der allgemeinen Hygieneregeln (Abstand von mind. 1,5 m, Hände waschen/desinfizieren).
  • Keine Termine bei akuten Erkältungssymptomen oder Kontakt zu Covid-Erkrankten in den letzten zwei Wochen.

Klinik für Plastische und Handchirurgie

Hugstetter Straße 55
79106 Freiburg

Telefon: 0761 270-27790

Montag-Freitag 10:00-13:00

Ärztlicher Direktor
Bevorstehende Veranstaltungen
Zertifikate